Benzodiazepines should still be first-line treatment for alcohol withdrawal

Gro Askgaard, Anton Pottegård, Anders Fink-Jensen

Publikation: Bidrag til tidsskriftReviewForskningpeer review

Resumé

In this review, we summarize the evidence for benzodiazepines and barbiturates as alcohol withdrawal treatment and outline a treatment guideline. A number of randomized controlled trials (RCTs) indicate that benzodiazepine treatment decreases alcohol withdrawal seizures and is safe. For barbiturates, only a few RCTs have been undertaken, and barbiturates were not found to be superior to benzodiazepines. Consequently, we suggest that benzodiazepines should still be first-line treatment for alcohol withdrawal.

OriginalsprogEngelsk
TidsskriftUgeskrift for Laeger
Vol/bind179
Udgave nummer3
Sider (fra-til)2-5
ISSN0041-5782
StatusUdgivet - 2017

Fingeraftryk

Alcohols
Alcohol Withdrawal Seizures
Randomized Controlled Trials
Guidelines

Citer dette

Askgaard, Gro ; Pottegård, Anton ; Fink-Jensen, Anders. / Benzodiazepines should still be first-line treatment for alcohol withdrawal. I: Ugeskrift for Laeger. 2017 ; Bind 179, Nr. 3. s. 2-5.
@article{e6b5afa988b84b6696943553c917938d,
title = "Benzodiazepines should still be first-line treatment for alcohol withdrawal",
abstract = "In this review, we summarize the evidence for benzodiazepines and barbiturates as alcohol withdrawal treatment and outline a treatment guideline. A number of randomized controlled trials (RCTs) indicate that benzodiazepine treatment decreases alcohol withdrawal seizures and is safe. For barbiturates, only a few RCTs have been undertaken, and barbiturates were not found to be superior to benzodiazepines. Consequently, we suggest that benzodiazepines should still be first-line treatment for alcohol withdrawal.",
author = "Gro Askgaard and Anton Potteg{\aa}rd and Anders Fink-Jensen",
year = "2017",
language = "English",
volume = "179",
pages = "2--5",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "3",

}

Benzodiazepines should still be first-line treatment for alcohol withdrawal. / Askgaard, Gro; Pottegård, Anton; Fink-Jensen, Anders.

I: Ugeskrift for Laeger, Bind 179, Nr. 3, 2017, s. 2-5.

Publikation: Bidrag til tidsskriftReviewForskningpeer review

TY - JOUR

T1 - Benzodiazepines should still be first-line treatment for alcohol withdrawal

AU - Askgaard, Gro

AU - Pottegård, Anton

AU - Fink-Jensen, Anders

PY - 2017

Y1 - 2017

N2 - In this review, we summarize the evidence for benzodiazepines and barbiturates as alcohol withdrawal treatment and outline a treatment guideline. A number of randomized controlled trials (RCTs) indicate that benzodiazepine treatment decreases alcohol withdrawal seizures and is safe. For barbiturates, only a few RCTs have been undertaken, and barbiturates were not found to be superior to benzodiazepines. Consequently, we suggest that benzodiazepines should still be first-line treatment for alcohol withdrawal.

AB - In this review, we summarize the evidence for benzodiazepines and barbiturates as alcohol withdrawal treatment and outline a treatment guideline. A number of randomized controlled trials (RCTs) indicate that benzodiazepine treatment decreases alcohol withdrawal seizures and is safe. For barbiturates, only a few RCTs have been undertaken, and barbiturates were not found to be superior to benzodiazepines. Consequently, we suggest that benzodiazepines should still be first-line treatment for alcohol withdrawal.

M3 - Review

VL - 179

SP - 2

EP - 5

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 3

ER -